Smoldering Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Smoldering Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
A Dana-Farber Cancer Institute-led clinical study recruiting to investigate molecular progression and clinical outcomes in MGUS, smoldering …
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating whether metformin can prevent progression from precursor conditions to active multiple myeloma.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study [NA]
A pilot clinical trial evaluating the effects of a Korean-style Mediterranean diet (KORMED) and physical activity measurement in patients wi…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
The CHAAMP internal pilot study is currently recruiting. It targets multiple myeloma and related plasma cell disorders, including MGUS and s…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma [EARLY_Phase 1]
Early-phase 1 clinical trial update evaluating leflunomide for high-risk smoldering multiple myeloma; the study is currently active but not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma [Phase 3]
Phase 3 clinical trial update reporting results for subcutaneous daratumumab versus active monitoring in participants with high-risk smolder…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma [Phase 3]
Phase 3 trial comparing subcutaneous daratumumab to active monitoring in high-risk smoldering multiple myeloma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating a personalized vaccine for patients with smoldering multiple myeloma has completed. The record ind…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma [Phase 1]
Phase 1 open-label trial of belantamab mafodotin in high-risk smoldering multiple myeloma is ongoing, with an extension cohort at a single c…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma [Phase 3]
Phase 3 trial evaluating isatuximab in combination with lenalidomide and dexamethasone for high-risk smoldering multiple myeloma; currently …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: European Myeloma Network (EMN) Sample Project
A European Myeloma Network study evaluating treatment options for multiple myeloma and related plasma cell disorders is currently recruiting…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) [NA]
A clinical trial is evaluating a plant-based diet and dietary supplements in people with smoldering multiple myeloma or monoclonal gammopath…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma [Phase 2]
Phase 2 trial evaluating lenalidomide with or without pomalidomide in combination with dexamethasone for multiple myeloma; the study was ter…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss
This clinical trial update reports the development and pilot testing of a new magnetic resonance imaging protocol to quantify multiple myelo…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program [NA]
This is a clinical trial update for a screening and patient navigation program aimed at early detection of multiple myeloma and related diso…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Screening for AL Amyloidosis in Smoldering Multiple Myeloma
This clinical trial update indicates ongoing recruitment for a study screening for AL amyloidosis in people with smoldering multiple myeloma…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial (TG01/QS-21 vaccine) is evaluating a peptide vaccine with QS-21 adjuvant in high-risk smoldering multiple myeloma…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma [Phase 2]
Phase 2 clinical trial evaluating immunotherapy with isatuximab and iberdomide for high-risk smoldering multiple myeloma; currently recruiti…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: DARA RVD For High Risk SMM [Phase 2]
A Phase 2 trial investigates adding daratumumab to the RVD regimen for high-risk Smoldering multiple myeloma and multiple myeloma; the study…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Immuno-PRISM (PRecision Intervention Smoldering Myeloma) [Phase 2]
Phase 2 Immuno-PRISM trial evaluating a precision intervention for smoldering multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Whole Body MRI in Oncology
This clinical trial update describes a study evaluating whole-body MRI in oncology across multiple cancer types, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma [Phase 2]
Phase 2 trial evaluating ixazomib, lenalidomide, and dexamethasone in smoldering multiple myeloma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) [NA]
A Memorial Sloan Kettering Cancer Center trial is evaluating a plant-based diet in people with Monoclonal Gammopathy of Undetermined Signifi…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients [Phase 2]
Phase 2 study of denosumab in high-risk smoldering multiple myeloma and SLiM-CRAB positive early multiple myeloma patients has completed.